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Abstract A cDNA fragment containing the Pisum sativum
GapN gene, which encodes the non-phosphorylating glyceralde-
hyde-3-phosphate dehydrogenase, was cloned in a prokaryote
expression vector. This construct enabled Escherichia coli strain
W3CG, a mutant which lacks the glycolytic phosphorylating
G3P dehydrogenase, to grow aerobically on sugars. The
functionally complemented mutant exhibited high levels of the
catalytically active plant enzyme, which renders 3-phosphoglyc-
erate and NADPH, thus bypassing the first substrate level
phosphorylation step of the glycolysis. As expected if such a
glycolytic bypass would be operative in vivo, this clone failed to
grow anaerobically on sugars in contrast to W3CG clones
complemented with phosphorylating glyceraldehyde-3-phosphate
dehydrogenases. According to the irreversible catabolic character
of the non-phosphorylating reaction, the GapN-complemented
clone was unable to grow on gluconeogenic substrates. This
metabolic engineering approach demonstrates that a pure
catabolic Embden-Meyerhof pathway with no net energy yield
is feasible.
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1. Introduction
Two phosphorylating D-glyceraldehyde-3-phosphate dehy-
drogenases (GAPDH) that perform key roles in the carbon
metabolism are present in photosynthetic eukaryotic organ-
isms: the cytosolic NAD-dependent GAPDH (EC 1.2.1.12)
of the glycolysis/gluconeogenesis and the chloroplastic
NADP-dependent GAPDH (EC 1.2.1.13) of the photosyn-
thetic Calvin cycle [1]. Both enzymes catalyze the same rever-
sible reaction, the oxidation of D-glyceraldehyde-3-phosphate
(G3P) to 1,3-bisphosphoglycerate (1,3-BPGA) with the con-
comitant addition of a molecule of Pi, but they are coded by
distinct, although related, nuclear genes (GapC and GapA/B,
respectively), di¡er in the coenzyme speci¢city and are located
in di¡erent cellular compartments [2,3]. All photosynthetic
eukaryotes investigated so far, both plants and microalgae,
contain in addition a third, distinctive, cytosolic non-phos-
phorylating NADP-dependent G3P dehydrogenase, or
G3P:NADP oxidoreductase (GAPDHN, EC 1.2.1.9), en-
coded by the nuclear gene GapN that irreversibly oxidizes
G3P to 3-phosphoglycerate (3-PGA) with the concomitant
addition of a molecule of H2O [4^7]. As a member of the
aldehyde dehydrogenase superfamily, the GAPDHN di¡ers
from GAPDHs both in primary structure and molecular
mass [4,5,8]. On the other hand, the ubiquitous NAD-depend-
ent GAPDH involved in the glycolysis/gluconeogenesis is en-
coded in eubacteria by a heterogeneous family of GapC-like
genes [1], but photosynthetic cyanobacteria possess in addi-
tion a phosphorylating NAD(P)-dependent enzyme
(GAPDH2, EC 1.2.1.59), encoded by the GapA-like gene
gap2 [9].
The cytosolic GAPDH is responsible for the ¢rst substrate
level phosphorylation step of the glycolysis, rendering 1,3-
BPGA, the substrate of 3-PGA kinase which eventually pro-
duces 3-PGA and ATP [1]. The GAPDHN, in contrast, does
not use Pi as a substrate and directly produces 3-PGA, thus
bypassing the ATP-generating reaction [5,7]. It has been pro-
posed [4,7] that the cytosolic GAPDHN could participate,
with the cooperation of the chloroplastic GAPDH and the
triose-phosphate/Pi translocator of the chloroplast inner mem-
brane [10], in the indirect shuttling of reducing power (H3)
and protons from the chloroplast stroma to the cytosol, thus
contributing to the maintenance of the pH gradient between
these two cellular compartments.
Functional complementation of the Escherichia coli gap mu-
tant W3CG, which has a Tn10 transposon inserted in the
GapC-like gene gap-2 and lacks GAPDH [11], has been used
as a cloning strategy for eubacterial gap genes [9,12,13]. We
have cloned the pea GapN gene under a strong lac-derived
promoter in the prokaryote expression vector pTrc 99A, so
that a functional plant GAPDHN could be expressed in E.
coli. This construct partially complemented the W3CG E. coli
strain, which recovered the ability to grow aerobically on
sugars but failed to perform anaerobic sugar fermentation
or aerobic growth on gluconeogenic substrates. This metabol-
ic engineering approach illustrates the operation of a strict
catabolic glycolytic pathway with no net substrate level phos-
phorylation. To our knowledge, this is the ¢rst time that such
a route has been demonstrated in vivo.
2. Materials and methods
All chemicals were of analytical grade and were purchased from
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Sigma-Aldrich Chemical or Merck. Restriction and modi¢cation en-
zymes were from Pharmacia Biotech.
2.1. Organisms and growth conditions
Wild-type E. coli strain K12 and strain W3110, its derived strain
W3CG (E. coli W3110 gap-2 : :Tn10 [11]) and complemented W3CG
clones were cultured at 37‡C in Luria-broth (LB) or minimal M63
media supplemented with the following organic carbon sources: (a) 20
mM glucose, (b) 20 mM Na-succinate plus 5 mM glycerol or (c) 20
mM Na-succinate plus 20 mM Na-acetate. Other sugars used (at 20
mM) instead of glucose were fructose, galactose, maltose, mannose
and sucrose. Either solid (plus 1.5%, w/v, Difco-Bactoagar) or liquid
cultures with continuous stirring were used. When necessary, ampicil-
lin (Ap) or tetracycline (Tet) were added at a concentration of 100 Wg/
ml or 25 Wg/ml, respectively. Growth rates of the di¡erent cultures
were determined in 96 well (250 Wl each) microtiter plates using an
Applied Biosystem microtiter lector with 10 agitation cycles per mi-
nute and measurements of A690 every hour for a 48 h cycle. Anaerobic
growth conditions were achieved by bubbling the media for 1 h with
N2 into 100 ml screw-capped bottles that were closed inmediately
afterwards. When required, KNO3 was added to a 25 mM ¢nal con-
centration.
2.2. Enzyme assays and protein techniques
The phosphorylating G3P dehydrogenase oxidizing and reductive
activities were measured spectrophotometrically by monitoring
changes in the A340 as described in [6]. The GADPHN activity was
measured using the same procedure but without Pi or arsenate in the
reaction medium [4,6]. The esterase activity of GAPDHN was deter-
mined spectrophotometrically with p-nitrophenyl acetate (NPA) as
described in [14] for E. coli GAPDH except that the reaction pH
was 7.5. Its optimal pH was estimated in the range from 6 to 11 using
di¡erent mixtures of Tris and glycine (50 mM total concentration) as
bu¡ers. One unit was de¢ned as the amount of enzyme able to reduce/
oxidize 1 Wmol of NAD(P)/NAD(P)H (dehydrogenase activity) or
hydrolyze 1 Wmol of NPA (esterase activity) per min. Polyacrylamide
gel electrophoresis of proteins in the presence of sodium dodecyl sul-
fate (SDS-PAGE) was carried out by the Laemmli method in 12% (w/
v) acrylamide slab gels using a Miniprotean-II (Bio-Rad) cuvette.
Other protein techniques were as described in [15].
The pea recombinant GAPDHN was puri¢ed to electrophoretic
homogeneity from cultures of the E. coli W3CG mutant transformed
with the pFVNP1 plasmid (see below) by a procedure modi¢ed from
that described for the GAPDH2 from the cyanobacterium Synecho-
cystis sp. PCC 6803 [9]. 100 ml of LB medium supplemented with Ap
and Tet were cultured until an A700 of 0.5 was reached. The expres-
sion was then induced for 3^6 h by 0.5 mM IPTG and the cells were
eventually harvested by centrifugation (15 000Ug, 10 min). Cell pellets
were washed twice in 50 mM Tris-HCl bu¡er, pH 7.5, and resus-
pended in the same bu¡er supplemented with 2 mM dithiothreitol,
2 mM phenylmethylsulfonyl £uoride and 10% (v/v) glycerol. After cell
breakage by ultrasonic treatment, a cell-free extract (soluble protein
fraction) was obtained by centrifugation (40 000Ug, 20 min) to re-
move cell debries and membranes. The puri¢cation protocol consisted
of a 40^85% ammonium sulfate fractionation of the cell-free extract
followed by three column chromatography steps, an ionic exchange
chromatography on DEAE-cellulose (DE-52 Whatman) and two con-
secutive hydrophobic chromatographies on Phenyl-Sepharose HP
(Pharmacia Biotech), the second one replacing the ¢nal a⁄nity cro-
matography step on Blue-Sepharose used in [9]. The recombinant
GAPDHs (GAPDH2 from Synechocystis sp. PCC 6803, GAPDH1
from Anabaena sp. PCC 7120 and GAPDH from E. coli) were puri¢ed
by the procedure described in [9]. Western blots were carried out after
SDS-PAGE of cell-free extracts as described in [9] by using mono-
speci¢c polyclonal antibodies raised in rabbits against the G3P dehy-
drogenases puri¢ed from the E. coli W3CG mutant transformed with
plasmids pFV8 (GAPDH2 of Synechocystis sp. PCC 6803) [9], pFVA1
(GAPDH1 of Anabaena sp. PCC 7120) and pFVNP1 (Pisum sativum
GAPDHN) (see below).
2.3. Cloning strategy and DNA manipulation
Plasmid pFVNP1 was constructed from plasmid pPsGAPN1 [8], a
pBS SK (Stratagene) derivative with a cDNA fragment of 1.63 kb
containing the GapN gene from pea (P. sativum) and the prokaryote
Fig. 1. Subcloning of the pea GapN gene from the original pPsGAPN1 plasmid into the expression vector pTrc 99A. amp, ampicillin resistant
gene; ori, origin of replication; Ptrc, lac-derived trc promoter; GapN, gene for the GAPDHN from P. sativum.
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expression vector pTrc 99A (Pharmacia Biotech) (Fig. 1). A PCR
ampli¢cation was carried out at 50‡C with two strict oligonucleotides
(forward, 5P-ATTTCCTACCATGGCTGC-3P ; reverse, 5P-AATATG-
CTACCGATTATT CTTAAGAT-3P) using plasmid pPsGAPN1 as a
template. In this way, a new Nco I restriction site (in bolds in the
forward primer) was created at the 5P-end of the gene incorporating
the start codon ATG (underlined) at the beginning of the translated
sequence and another Nco I site present in the natural sequence was
deleted at the 3P-end. This strategy also created an EcoR I site (in
bolds in the reverse primer) after two stop codons (underlined) orig-
inally present in the GapN gene. The 1.52 kb DNA fragment thus
obtained was ligated into the pGEM-T vector (Promega) and trans-
formed into E. coli DH5K strain, three independent clones (named
pFVNPTa, b and c) being selected and tested by restriction analysis.
These plasmids were restricted with Nco I-EcoR I endonucleases and
the resulting 1.49 kb DNA fragment was ligated into plasmid pTrc
99A restricted with the same enzymes, so that the GapN gene was
directionally cloned with the ATG of the Nco I site immediately after
the trc promoter. A BamH I-Hind III fragment of 1.26 bp was ex-
tracted from the original pPsGAPN1 vector by partial restriction and
ligated into the BamH I-Hind III-restricted pFVNPa, b and c plas-
mids. These plasmids were transformed into E. coli DH5K and cell-
free extracts were obtained as above and tested for GAPDH and
GAPDHN activities. Plasmid pFVNP1 was obtained from one of
these constructs (pFVNTa) and 300 bp starting from both ends of
the Nco I-EcoR I insert were sequenced in both strands to con¢rm
that no mutation either due to PCR or ligation processes occurred.
Plasmid pFVA1 was obtained by functional complementation in LB-
Ap (50 Wg/Wl) medium of E. coli W3CG transformed with a DNA
library from the cyanobacterium Anabaena sp. PCC 7120 in pBS SK
[9] and subcloning until no other complete open reading frame than
the one corresponding to the gapC-like gap1 gene was present in the
vector insert (approximately 3 kb). Plasmid pF61A is a pBR322 de-
rivative containing the gapC gene of E. coli K12 [16].
3. Results and Discussion
Fig. 1 shows the construction of plasmid pFVNP1, which
contains the pea GapN gene (1488 bp corresponding to a
polypeptide of 496 amno acids (aa)) under the control of a
strong trc promoter, from the cDNA insert of plasmid
pPsGAPN1 [8]. Since the cloning strategy involved a PCR
step, most of the original translated region (1257 bp) was
re-introduced in the ¢nal construct and the rest was checked
by sequencing. In this way, a high transcription level of the
GapN gene and, consequently, a high production of the 52
kDa GAPDHN protein were expected in E. coli cells in the
presence of the IPTG inducer. To avoid any contamination
with the host GAPDH, we used the E. coli gap mutant
W3CG, which has the gapC gene disrupted by insertional
mutagenesis [11]. This strain, that fails to metabolize sugars,
showed an aerobic growth in minimal medium with glucose as
the sole carbon source when transformed with pFVNP1, so
the gap phenotype was regained, although lower growth
rates than the wild-type K-12 strain were observed (5 h versus
1.5 h, doubling times). However, in contrast with the wild-
type, no growth was observed in M63 medium supplemented
with gluconeogenic substrates (acetate plus succinate) (see be-
low). Cell-free extracts from this complemented clone exhib-
ited in the presence of G3P an irreversible and Pi (or arsen-
ate)-independent generation of NADPH that was markedly
inhibited by Pi (Fig. 2A, ¢rst kinetic). This distinctive feature
of the non-phosphorylating G3P dehydrogenase reaction [4,5]
indicated that the functional plant GAPDHN was present in
the bacterial extracts. Moreover, the speci¢c activity achieved
(0.7^1.0 U/mg of protein) was two orders of magnitude higher
than that found in photosynthetic cells [4,6]. Since the natural
Fig. 2. (A) G3P dehydrogenase reductive activities determined spec-
trophotometrically at 340 nm in the presence or absence of Pi in
cell-free extracts from W3CG clones transformed with plasmids con-
taining di¡erent gap genes. From top to bottom: W3CG/pFVNP1,
producing the GAPDHN from P. sativum ; W3CG/pFV8, producing
the NAD(P)-dependent GAPDH2 from Synechocystis sp. PCC
6803; W3CG/pFVA1, producing the NAD-dependent GAPDH1
from Anabaena sp. PCC 7120 and W3CG/pF61A, producing the
NAD-dependent GAPDH from E. coli K-12. (R/O) NADP-de-
pendent activity with/without Pi; (b/a) NAD-dependent activity
with/without Pi. (B) Western blots of cell-free extracts corresponding
to the W3CG clones showed in A using monospeci¢c antibodies
against: pea GAPDHN (lane a), Synechocystis GAPDH2 (lane b)
and Anabaena GAPDH1 (lane c). About 50 Wg of protein was
loaded per lane, fractionated by SDS-PAGE and transferred to ni-
trocellulose membranes. The apparent molecular masses of the im-
munodetected protein bands are indicated. (C) Coomassie blue-
stained SDS-PAGE electropherogram of cell-free extracts (50 Wg of
protein per lane) from the W3CG clones described above, showing
the level of overproduction achieved and the corresponding puri¢ed
recombinant proteins (5^10 Wg per lane) on their right. 1, W3CG/
pFVNP1; 1P, puri¢ed pea GAPDHN (52 kDa subunit); 2, W3CG/
pFV8; 2P, puri¢ed Synechocystis GAPDH2 (38 kDa subunit); 3,
W3CG/pFVA1; 3P, puri¢ed Anabaena GAPDH1 (37 kDa subunit);
4, W3CG/pF61A and 4P, puri¢ed E. coli GAPDH (36 kDa subunit).
The apparent molecular masses of the recombinant proteins are in-
dicated on the right margin.
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E. coli GAPDH is not present in the complemented W3CG
clone (no NAD-dependent GAPDH activity was detected),
the only possible pathway of sugar catabolism must be, there-
fore, a modi¢ed Embden-Meyerhof route with an irreversible
and non-phosphorylating bypass involving the GAPDHN.
Failure to grow with acetate plus succinate is in agreement
with this proposal. Although functional complementation of
E. coli gap mutants has been achieved with di¡erent GAPDHs
[9,12,13], to our knowledge, this is the ¢rst time that a non-
phosphorylating G3P dehydrogenase has been used for this
purpose.
For comparison, the E. coli W3CG strain was also trans-
formed with plasmids harboring genes which encode three
di¡erent bacterial GAPDHs: pFV8, containing the gap2
gene from the unicellular cyanobacterium Synechocystis sp.
PCC 6803 [9], pFVA1, having the gap1 gene from the ¢la-
mentous cyanobacterium Anabaena sp. PCC 7120 ([9] and this
work) and pF61A, with the gapC gene from E. coli [16]. All
these plasmids, although derived from di¡erent vectors, have
genomic DNA inserts of similar sizes (2^3 kb) containing both
the bacterial gap genes and its corresponding natural pro-
moters. Consequently, these constructs functionally comple-
mented the W3CG gap mutant and cell-free extracts of the
complemented clones exhibited high levels of reversible phos-
phorylating G3P dehydrogenase activity, in the absence of
IPTG. Noteworthy, the pFV8-transformed clone showed
comparable levels (4^6 U/mg of protein) of both NAD- and
NADP-dependent activities, as it was expected since the cya-
nobacterial GAPDH2 is able to reduce both cofactors with a
similar e⁄ciency [9] (Fig. 2A, second kinetic). In contrast, the
cyanobacterial GAPDH1 (6^10 U/mg of protein) and the E.
coli GAPDH (12^15 U/mg of protein), produced by the
W3CG/pFVA1 and W3CG/pF61A clones, respectively, are
NAD-dependent glycolytic enzymes (Fig. 2A). The diverse
speci¢c activity values obtained could result from di¡erences
in the expression levels achieved by each particular plasmid. It
should be noted that, in contrast to the GapN-complemented
W3CG clone, the three clones harboring recombinant
GAPDHs are able, as the wild-type is, to fermentate sugars
and grow on gluconeogenic substrates (acetate plus succinate)
as the sole carbon sources (see below).
The presence of only one G3P dehydrogenase protein in the
di¡erent W3CG-transformed clones was clearly demonstrated
by Western analysis of cell-free extracts using three di¡erent
monospeci¢c polyclonal antibodies raised against pea
GAPDHN and the cyanobacterial enzymes GAPDH2 and
GAPDH1. As can be seen in Fig. 2B, each antibody immu-
nodetected only its respective antigenic protein and neither of
the three reacted with the E. coli GAPDH [16]. The overex-
pression levels achieved in the recombinant clones allowed us
to visualize the G3P dehydrogenase proteins as major bands
in the corresponding SDS-PAGE analysis of cell-free extracts
(Fig. 2C). The apparent molecular masses of the puri¢ed re-
combinant proteins (52, 38, 37 and 36 kDa for GAPDHN,
GAPDH2, GAPDH1 and E. coli GAPDH, respectively) cor-
relate well with those predicted from gene sequences and
match with the immunodetected protein bands. The overex-
pression level of E. coli GAPDH is evidently higher than all
the other three recombinant enzymes and can be explained by
the fact that the transcription is performed from a multicopy
plasmid containing both the promoter and the encoding re-
gion of the bacterial host enzyme. Overall, these results con-
¢rm the identity of the recombinant G3P dehydrogenases and
the corresponding natural enzymes.
Further kinetic studies also con¢rmed the identity of natu-
ral and recombinant GAPDHNs. The puri¢ed recombinant
plant GAPDHN from the transformed W3CG clone (puri¢-
cation factor approximately 40-fold, yield 70%) presented a
speci¢c activity of about 20 U/mg protein. Calculated Km
values were 17 þ 2 and 30 þ 3 WM (means of three independent
determinations) for NADP and D-G3P, respectively, the ac-
tivity being strictly dependent on D-G3P and strongly inhib-
ited (Ki, 50 þ 3 WM) by the L-isomer of the triose. Although
the optimal pH of the recombinant GAPDHN was somewhat
lower than those of natural enzymes (7.5 versus 8.5), the over-
all results are in good agreement with those reported for the
dehydrogenase reaction of native plant and algal GAPDHNs
[4,5]. On the other hand, GAPDHs as well as the members of
the aldehyde dehydrogenase family exhibit an esterase activity
with NPA which involves the same aa residues than the de-
hydrogenase reactions [14]. We have now found that both
natural and recombinant pea GAPDHNs exhibit a esterase
activity, the Km value for NPA being 0.3 þ 0.02 mM in both
cases. This value is clearly lower than those calculated for
GAPDHs (i.e. Km(NPA) = 1.2 þ 0.05 mM for GAPDH2). To
our knowledge, this is the ¢rst report on the esterase activity
of a GAPDHN.
As mentioned above, the pFVNP1-transformed W3CG
clone exhibited growth characteristics di¡erent from those of
the recombinant clones producing GAPDHs or the wild-type
K-12 strain (used as a control) when tested in various culture
media (LB or M63 supplemented with di¡erent carbon sour-
ces). Similar aerobic growth rates (4^6 h, doubling times) were
obtained in M63 medium with glucose for pF61A-, pFV8-
and pFVNP1-transformed clones, indicating that GAPDHN
is e⁄ciently working in the sugar catabolism under these con-
ditions, but all transformant clones showed lower growth
rates than the wild-type strain (doubling time, 1.5 h). The
GAPDHN-producing W3CG clone exhibited reduced growth
rates in M63 media supplemented with other sugars, in ac-
cordance with the preference order for these substrates previ-
ously reported for the wild-type E. coli strain [17,18]. Surpris-
ingly, the pFVA1-transformed mutant producing the
cyanobacterial GAPDH1 has a much higher doubling time
(approximately 9 h), indicating that this enzyme does not
complement the gap mutation as e⁄ciently as the others (cf.
[9]). Noteworthy, the GAPDHN-producing clone failed to
grow on M63 medium supplemented with the gluconeogenic
substrates succinate plus acetate, showing in this medium the
same pattern as the parental W3CG strain, while all three
GAPDH-producing clones exhibited growth rates similar to
the wild-type strain (7^9 h, doubling times). All transformant
clones presented aerobic growth rates (5^7 h, doubling times)
comparable to the parental W3CG strain in the non-selective
succinate plus glycerol M63 medium.
Dramatic di¡erences were also found in the anaerobic
growth patterns of the GAPDHN and the GAPDH-produc-
ing W3CG clones in glucose-supplemented media, no growth
being observed with the GapN-expressing clone (Fig. 3). Since
under these conditions glycolysis is the only energy-supplying
route for the enterobacterium, the lack of growth of the
pFVNP1-transformed clone is the result of the in vivo oper-
ation of a non-phosphorylating bypass involving the
GAPDHN, i.e. a modi¢ed glycolytic pathway with no energy
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yield. Nitrate, that can replace oxygen as the terminal electron
acceptor in the respiratory chain, does not revert this growth
failure (Fig. 3).
Another remarkable growth characteristic of the pFVNP1-
transformed W3CG clone is the marked acidi¢cation of the
medium, a decrease of 1^1.5 U of pH in the weak-bu¡ered
culture media being observed for the GAPDHN-producing
clone (pH circa 6.0^6.5) when compared to clones producing
GAPDHs (pH circa 7.5). In connection with this, it should be
noted that the puri¢ed GAPDHN produces an intense acid-
i¢cation of the assay medium as a consequence of the irrever-
sible Pi-independent G3P dehydrogenase reaction that it cata-
lyzes [7] :
G3P  NADP  H2O! PGA  NADPH 2H
This reaction has both kinetic and thermodinamic charac-
teristics very di¡erent from the reversible Pi-dependent overall
reaction catalyzed by GAPDH and PGA kinase:
G3P  NAD  ADP  PiI PGA  NADH  ATP  H
Thus, although no ATP is produced by the GAPDHN re-
action, two protons are generated as a result of water ioniza-
tion [7].
The fact that the GAPDHN is able to functionally comple-
ment the gap mutation, producing a modi¢ed glycolytic path-
way, suggests that it could have an equivalent function in its
natural environment (the plant or algal cytosol). Experiments
with the green alga Chlorella fusca showing the occurrence of
a di¡erential regulation by trophic conditions of the three
algal G3P dehydrogenases [19] also indicate that, in the pres-
ence of metabolizable sugars, the GAPDHN can compete
with advantage over the cytosolic NAD-dependent GAPDH
due to its lower Km values for G3P and the pyridine nucleo-
tide. Thus, the substrate availability and enzyme kinetic char-
acteristics could explain why the pFVNP1-transformed clone
exhibited in minimal media with sugars growth rates compar-
able to the GAPDH-producing W3CG transformants, despite
having about 10-fold less of both recombinant protein and
G3P dehydrogenase activity. The presumable function of
GAPDHN in a non-phosphorylating bypass of the glycolysis
in plants and algae, together with the presence of a pyrophos-
phate(PPi)-dependent phosphofructokinase in these organ-
isms, could be adaptations of photosynthetic eukaryotes to
phosphate de¢ciency, a trophic stress condition often found
in their natural environments that drastically reduces the cel-
lular pools of both Pi and nucleotides, but not the PPi cellular
pool [20]. These photosynthetic cells could overcome this sit-
uation by using the Pi-independent or PPi-dependent glyco-
lytic reactions, adenine nucleotides being likely reserved for
photosynthetic phosphorylation.
It was reported that GAPDHN activity was neither de-
tected in non-photosynthetic eukaryotes, nor in eubacteria
and archaea [4,6]. However, this enzyme was later found in
some prokaryotic microorganisms, a GAPDHN similar to the
plant enzyme having been discovered in certain cariogenic
Streptococcus strains that lack the NADPH-generating en-
zymes of the oxidative pentose phosphate pathway [21]. These
strains also contain the NAD-dependent phosphorylating
GAPDH and a regulation of sugar degradation similar to
that of photosynthetic eukaryotes has been proposed, either
NADPH or ATP being generated depending of the metabolic
demands of the cell. Moreover, it has recently been found [22]
that the hyperthermophilic archaeum Thermoproteus tenax
Fig. 3. Comparison of growth (absorbance at 700 nm) under di¡er-
ent metabolic conditions of 48 h old cultures of E. coli W3CG
clones transformed with either plasmid pF61A, producing the E.
coli K-12 GAPDH, or plasmid pFVNP1, producing the pea
GAPDHN. Cultures were grown at 37‡C in M63 liquid media sup-
plemented either with glucose (G) or succinate plus glycerol (S+Gl)
under aerobiosis, anaerobiosis and anaerobiosis in the presence of
potassium nitrate. Results are mean values ( þ S.D.) of three inde-
pendent determinations.
Fig. 4. The phosphorylating and non-phosphorylating branches of
the glycolysis, that should be functional in the recombinant E. coli
W3CG clones containing, respectively, either the bacterial NAD-de-
pendent GAPDHs or the plant GAPDHN, are boxed in this meta-
bolic scheme showing the trunk glycolytic route and its connections
with other central and peripheral pathways. The reaction in which
the W3CG strain is defective is shown in dashed arrows. The sub-
strates used as carbon sources in this work have also been high-
lighted. TCA, tricarboxylic acid cycle; FA, fatty acids pool; aa,
amino acids pool.
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posseses, in addition to the GAPDH, a NAD-dependent
GAPDHN that, although related to the plant enzyme, seems
to be strongly regulated by the energy charge of the cell. This
enzyme could have a catabolic role without any energy yield,
deriving a quick pool of metabolites for other reactions. This
assumption is further assesed by our recombinant pFVNP1-
transformed W3CG clone, in which the strict catabolic role of
the GAPDHN is established since no other GAPDH is
present and the reaction is irrerversible.
The phosphorylating and non-phosphorylating branches of
the glycolysis presumably operative in the recombinant E. coli
W3CG clones described in this work and in the organisms
cited above are diagramatically represented in Fig. 4, together
with other central and peripheral metabolic pathways.
Summarizing, we have shown that the replacement of a
single key enzyme in a central metabolic pathway can produce
dramatic modi¢cations in the physiology and growth charac-
teristics of the bacterial host. This metabolic engineering ap-
proach has demonstrated the in vivo operation of a non-phos-
phorylating bypass involving a glycolytic route with no net
energy yield that may be functional in photosynthetic eukar-
yotes and some bacteria. This work also illustrates the possi-
ble application of this strategy in the biotechnology of fermen-
tative processes.
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